Information about Gans Investors
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0865.470.523

VAT liability
Yes
Established
13-05-2004
Last balance sheet year
2024
Company size
Small 0 FTE
Commercial name
Apotheek Rooseleers
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Gans Investors

2024 2023 2022 2021
Profit/Loss 138,678 40 % 98,917 35 % 73,230 -19 % 90,662
Equity 772,704 21 % 639,027 18 % 540,109 16 % 466,880
Gross margin 93,768 24 % 75,852 45 % 52,200 -38 % 83,711

Publications from Gans Investors

Date Publication
27-07-2023 Capital - Shares - Resignations - Appointments (NL)
08-01-2018 Designation - Registered Office - Goal - Capital - Shares (NL)
21-03-2014 Capital - Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
08-06-2004 Constitution (NL)

Frequently asked questions

What is the VAT number of Gans Investors?
The VAT number of Gans Investors is BE 0865.470.523.
Wat is the PEPPOL ID of Gans Investors?
There is no information available about the PEPPOL ID of Gans Investors or the company is not yet registered on the PEPPOL network.
When was Gans Investors founded?
Gans Investors was founded on 13-05-2004.
What is the address of Gans Investors?
The current registered office of Gans Investors is located at Mollenveldwijk 22A, 3271 Scherpenheuvel-Zichem.
When was the last time Gans Investors filed their annual financial statements?
The most recent financial statements of Gans Investors were filed on 31-07-2025.
How many employees does Gans Investors have?
There are currently no employees working at Gans Investors or no workforce information is available.
What is the annual turnover of Gans Investors?
At the time of its most recent financial statements, Gans Investors did not publish any turnover figures. Gans Investors reported a gross margin of €93,767.56.